Another study tested several metabolic inhibitors including BEZ235, GDC0980 (dual PI3K/mTOR inhibitors), or LY294002 and GDC0942 (PI3K inhibitors) showing an inhibition of cell proliferation of breast cancer cells in high glucose media (54). This evidence concerns the gene PIK3CG and breast carcinoma.